» Articles » PMID: 38947072

Differences in HIV-1 Reservoir Size, Landscape Characteristics and Decay Dynamics in Acute and Chronic Treated HIV-1 Clade C Infection

Overview
Journal medRxiv
Date 2024 Jul 1
PMID 38947072
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Persisting HIV reservoir viruses in resting CD4 T cells and other cellular subsets are the main barrier to cure efforts. Antiretroviral therapy (ART) intensification by early initiation has been shown to enable post-treatment viral control in some cases but the underlying mechanisms are not fully understood. We hypothesized that ART initiated during the hyperacute phase of infection before peak will affect the size, decay dynamics and landscape characteristics of HIV-1 subtype C viral reservoirs.

Methods: We studied 35 women at high risk of infection from Durban, South Africa identified with hyperacute HIV infection by twice weekly testing for plasma HIV-1 RNA. Study participants included 11 who started ART at a median of 456 (297-1203) days post onset of viremia (DPOV), and 24 who started ART at a median of 1 (1-3) DPOV. We used peripheral blood mononuclear cells (PBMC) to measure total HIV-1 DNA by ddPCR and to sequence reservoir viral genomes by full length individual proviral sequencing (FLIP-seq) from onset of detection of HIV up to 1 year post treatment initiation.

Results: Whereas ART in hyperacute infection blunted peak viremia compared to untreated individuals (p<0.0001), there was no difference in total HIV-1 DNA measured contemporaneously (p=0.104). There was a steady decline of total HIV DNA in early treated persons over 1 year of ART (p=0.0004), with no significant change observed in the late treated group. Total HIV-1 DNA after one year of treatment was lower in the early treated compared to the late treated group (p=0.02). Generation of 697 single viral genome sequences revealed a difference in the longitudinal proviral genetic landscape over one year between untreated, late treated, and early treated infection: the relative contribution of intact genomes to the total pool of HIV-1 DNA after 1 year was higher in untreated infection (31%) compared to late treated (14%) and early treated infection (0%). Treatment initiated in both late and early infection resulted in a more rapid decay of intact (13% and 51% per month) versus defective (2% and 35% per month) viral genomes. However, intact genomes were still observed one year post chronic treatment initiation in contrast to early treatment where intact genomes were no longer detectable. Moreover, early ART reduced phylogenetic diversity of intact genomes and limited the seeding and persistence of cytotoxic T lymphocyte immune escape variants in the reservoir.

Conclusions: Overall, our results show that whereas ART initiated in hyperacute HIV-1 subtype C infection did not impact reservoir seeding, it was nevertheless associated with more rapid decay of intact viral genomes, decreased genetic complexity and immune escape in reservoirs, which could accelerate reservoir clearance when combined with other interventional strategies.

References
1.
Buchholtz N, Nuhn M, de Jong T, Stienstra T, Reddy K, Ndungu T . Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C. Virol J. 2024; 21(1):36. PMC: 10832250. DOI: 10.1186/s12985-024-02300-6. View

2.
Chun T, Stuyver L, Mizell S, Ehler L, Mican J, Baseler M . Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 1997; 94(24):13193-7. PMC: 24285. DOI: 10.1073/pnas.94.24.13193. View

3.
Boulassel M, Chomont N, Pai N, Gilmore N, Sekaly R, Routy J . CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. J Clin Virol. 2011; 53(1):29-32. DOI: 10.1016/j.jcv.2011.09.018. View

4.
Sterling T, Vlahov D, Astemborski J, Hoover D, Margolick J, Quinn T . Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med. 2001; 344(10):720-5. DOI: 10.1056/NEJM200103083441003. View

5.
Naidoo K, Ndumnego O, Ismail N, Dong K, Ndungu T . Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection. Front Immunol. 2021; 12:738743. PMC: 8498034. DOI: 10.3389/fimmu.2021.738743. View